Cobram Estate Olives And 2 Other ASX Penny Stocks To Watch

In This Article:

Australian shares are experiencing a period of volatility, with the ASX 200 futures indicating a slight upward movement amidst global uncertainties such as impending EU tariffs from the U.S. Penny stocks, though often seen as an outdated term, continue to present intriguing opportunities for investors willing to explore smaller or newer companies with solid financial foundations. In this context, we examine three Australian penny stocks that combine financial strength with potential growth prospects.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Bisalloy Steel Group (ASX:BIS)

A$3.14

A$150.42M

★★★★★★

Helloworld Travel (ASX:HLO)

A$1.66

A$270.28M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.465

A$288.37M

★★★★★☆

IVE Group (ASX:IGL)

A$2.34

A$362.44M

★★★★★☆

Southern Cross Electrical Engineering (ASX:SXE)

A$1.745

A$461.15M

★★★★★★

Perenti (ASX:PRN)

A$1.24

A$1.16B

★★★★★★

GTN (ASX:GTN)

A$0.535

A$105.06M

★★★★★★

MotorCycle Holdings (ASX:MTO)

A$1.81

A$133.59M

★★★★★☆

SHAPE Australia (ASX:SHA)

A$3.14

A$259.8M

★★★★★★

Accent Group (ASX:AX1)

A$2.02

A$1.14B

★★★★☆☆

Click here to see the full list of 1,033 stocks from our ASX Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Cobram Estate Olives

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Cobram Estate Olives Limited is involved in olive farming and the production and marketing of olive oil across Australia, the United States, and internationally, with a market cap of A$854.64 million.

Operations: The company's revenue segments include its US operation, which generated A$67.16 million.

Market Cap: A$854.64M

Cobram Estate Olives Limited, with a market cap of A$854.64 million, has shown promising financial trends despite challenges. The company's earnings grew significantly by 104.8% over the past year, outpacing the broader food industry and improving net profit margins to 8.9%. Although its debt level remains high with a net debt to equity ratio of 78.6%, interest payments are well covered by EBIT at 4.6 times coverage, and operating cash flow covers debt adequately at 24%. Recent earnings reported for H1 showed sales growth to A$124.77 million, though the company still posted a net loss of A$4.46 million compared to last year's larger loss.

ASX:CBO Debt to Equity History and Analysis as at Feb 2025
ASX:CBO Debt to Equity History and Analysis as at Feb 2025

CleanSpace Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: CleanSpace Holdings Limited designs, manufactures, and sells respiratory protection products and services for healthcare and industrial markets globally, with a market cap of A$37.04 million.